The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)
The unlimited clinician access is the most significant value-add
"While Big Pharma is also trying to blur the lines between unsafe and unregulated products, those are very different from compounded products
References to Wegovy reflect publicly available information about FDA-approved weight management medications for comparative context only
Here's what to know Trouble Getting Weight Loss Drugs Deborah Finley, 50, of Lodi, Calif., says her weight started to worry her during the early days of COVID
View the current altRx GLP-1 offer (official altRx page) What altRx Says About Insurance and Self-Pay According to altRx's published FAQ, insurance is not required and the program is structured as straightforward self-pay (cash-pay) care